NCT06276205View on ClinicalTrials.gov

Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Hypothyroidism PrimaryLipid DisorderDyslipidemias
Interventions
DRUG

Vitamin D

"if Vitamin D level suboptimal, 50,000 IU/week for 8 weeks followed by 2000 IU/d~if optimal Vitamin D level, 2000 IU/d"

DRUG

Levothyroxin

commenced at a dose of 1.6mcg/kg/day and will be titrated 8 weekly according to response

Trial Locations (1)

54000

King Edward Medical University, Lahore

All Listed Sponsors
lead

King Edward Medical University

OTHER

NCT06276205 - Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism | Biotech Hunter | Biotech Hunter